Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
67.11
1.57 (2.40%)
At close: Aug 15, 2025, 2:16 PM
Halozyme Therapeutics Revenue
Halozyme Therapeutics reported an annual revenue of $1.02B, reflecting a 22.44% growth. For the quarter ending June 30, 2025, Halozyme Therapeutics generated $325.72M in revenue.
Revenue (ttm)
1.02B
Revenue Growth
22.44%
Price / Sales Ratio
5.97
Revenue / Employee
2.9M
Employees
350
Market Cap
7.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|